The Study of Reducing Adverse Effects After Radiofrequency Ablation Combined With Sclerotherapy
Launched by CHENGDU UNIVERSITY OF TRADITIONAL CHINESE MEDICINE · Dec 7, 2022
Trial Information
Current as of January 14, 2025
Unknown status
Keywords
ClinConnect Summary
Chronic venous insufficiency(CVI)of the lower extremities is a commonly clinically syndrome。 It can manifest as telangiectasias (or spider veins), reticular veins, varicose veins(VVS), edema, pigmentation and/or eczema, liposomal sclerosis, white atrophy, and venous ulcers。 Patients often seek treatment for varicose veins because of cosmetic problems, pain, swelling, itching, ulcers, and other symptoms。 With the development of society, more and more patients require to choose local anesthesia, minimally invasive, and rapid recovery surgery. Radiofrequency ablation(RFA) combined with sclerot...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Age \>18 years and \<80 years, and able to understand the requirements of the study and provide informed consent and accept the exams and follow-up.
- • C2 - C5 varicose veins / CVI Symptomatic primary GSV, SSV, or AASV incompetence, with reflux \>0.5 seconds on color duplex, eligible for patients undergoing radiofrequency ablation plus sclerotherapy
- • BMI\<35
- • The skin color is within the normal range, and no obvious skin color unevenness or skin diseases affect the observed indicators.
- Exclusion Criteria:
- • Acute superficial or deep vein thrombosis
- • History of asthma and stroke
- • There are skin diseases, scars, infections, and other conditions in the surgical area that affect the observation indicators
- • Pregnancy
- • Serious damage to liver and kidney function
- • Severe obesity (BMI\>35) and severe edema of the lower extremities
- • Others are not eligible for intravenous radiofrequency ablation combined with sclerotherapy
About Chengdu University Of Traditional Chinese Medicine
Chengdu University of Traditional Chinese Medicine (CUTCM) is a prominent academic institution dedicated to the research and advancement of Traditional Chinese Medicine (TCM). Renowned for its rigorous educational programs and innovative research initiatives, CUTCM actively contributes to the integration of TCM with modern medical practices. The university emphasizes evidence-based research, aiming to validate and enhance traditional therapeutic methods through clinical trials and scientific inquiry. With a commitment to improving healthcare outcomes, CUTCM collaborates with various stakeholders to explore the efficacy and safety of TCM interventions, fostering a deeper understanding of holistic health approaches.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Chengdu, Sichuan, China
People applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Discussion 0
Similar Trials